Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ sells rights to RSV virus drug to Sobi for $1.5bn

pharmaphorumDecember 11, 2018

Tag: AZ , RSV , virus drug , Sobi

PharmaSources Customer Service